Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Human Genome Sciences (HGS) has selected cloud-based Veeva CRM (customer relationship management) to support the launch of Benlysta, FDA approved Lupus drug in Europe.
Subscribe to our email newsletter
Veeva CRM will help HGS with all specialty care sales reps and medical science liaisons in Germany, Spain and France.
According to HGS, Veeva’s pharmaceutical industry expertise and understanding of HGS’ sales model is the key to the smooth implementation.
HGS Europe marketing and sales operations associate director Kevin Crowe said Veeva CRM would help them improve customer traction by enabling their reps to more effectively measure calls and profile customers.
"Additionally, Veeva CRM is a great system for improving customer targeting, making us more efficient at turning non-prescribers into advocates," Crowe added.